Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination


Since cancer vaccines do not always elicit beneficial effects in treated patients, identification of biomarkers for predicting clinical outcomes would be highly desirable. We previously reported that abnormal granulocytes present in peripheral blood mononuclear cells (PBMC) may contribute to poor prognosis in advanced prostate cancer patients receiving… (More)
DOI: 10.1080/21645515.2015.1075107

4 Figures and Tables


  • Presentations referencing similar topics